FindTrial
Sign In

Prevalence and influence factors for delirium in patients with COVID-19

Prevalence and influence factors for delirium in patients with COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067933
Enrollment
Unknown
Registered
2023-01-31
Start date
2023-01-31
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

delirium

Interventions

Observation group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Adult patients (age >= 18 years) 2. SARS-CoV-2 nucleic acid/ antigen test were positive (or COVID-19 infection history within 1 month) 3. Voluntary participation in this study

Exclusion criteria

Exclusion criteria: 1. With communication barriers 2. Suffering from mental disorders

Design outcomes

Primary

MeasureTime frame
delirium;—

Secondary

MeasureTime frame
Cognitive state;mortality;Complication;Quality of Life;Activities of daily living;—

Countries

China

Contacts

Public ContactQian Chen

West China Hospital, Sichuan University

hxqianchen@126.com+86 18980606114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026